Original Research

Management Strategies of Ultrasound Department in Response to the Epidemic Crisis

  • Chen, MD Jie ,
  • Zhang, MD Bo ,
  • Yang, MB Mo ,
  • Tian, MD Yan ,
  • Guo, MS Dandan ,
  • Wang, MD Boya ,
  • Lu, MS Weidan ,
  • Ma, MS Jiaojiao ,
  • Zhao, MB Cui ,
  • Zang, MB Shuliang ,
  • Wang, MB Jianya
Expand
  • a Department of Ultrasound, China–Japan Friendship Hospital, Beijing, China

Received date: 2020-04-01

  Online published: 2020-04-18

Abstract

Objective: The coronavirus disease (COVID-19) epidemic occurred suddenly, and had a severe impact on the whole society, especially the health care system. The purpose of this article is to share the experience of infection control management in the ultrasound department of China-Japan Friendship Hospital in response to the epidemic.
Methods: In accordance with relevant academic guidance and consensus guidelines, the ultrasound department followed principles of prevention and control which were promulgated by the hospital, combined management measures with the characteristics of ultrasound diagnosis and treatment, to control infection during the epidemic period. These measures included reducing the number of patients and doctors, using targeted protection standards in different work areas, and strengthening the training of staff in the department.
Results: During the epidemic in February to March 2020, the ultrasound department completed a total of 10,719 cases in the outpatient area (a decrease of 68.3% compared with the same period last year) and 1,583 cases from emergency (including 53 cases from the fever clinic). While the clinical needs were met, there was zero infection with COVID-19 of all health care staff in the ultrasound department during the epidemic.
Conclusions: We hope the valuable experience of infection control management in our ultrasound department in response to the epidemic can help global ultrasound doctors be prepared for the pandemic. The teams of ultrasound departments should also work closely with local infection control colleagues to implement measures that are appropriate for their own clinical settings to overcome the pandemic.

Cite this article

Chen, MD Jie , Zhang, MD Bo , Yang, MB Mo , Tian, MD Yan , Guo, MS Dandan , Wang, MD Boya , Lu, MS Weidan , Ma, MS Jiaojiao , Zhao, MB Cui , Zang, MB Shuliang , Wang, MB Jianya . Management Strategies of Ultrasound Department in Response to the Epidemic Crisis[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2020 , 4(2) : 90 -98 . DOI: 10.37015/AUDT.2020.200032

References

[1] She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med 2020; 9:19. DOI: 10.1186/s40169-020-00271-z.
[2] Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054-1062.
[3] Office of National Health Office, Office of the National Administration of traditional Chinese medicine. Novel Coronavirus-infected Pneumonia diagnosis and treatment plan (Trial Seventh Edition).(GWB YH [2020] No. 184).
[4] Tang B, Bragazzi NL, Li Q, Tang S, Xiao Y, Wu J. An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov). Infect Dis Model 2020; 5:248-255.
[5] Beijing Ultrasonic Medical Quality Control and Improvement Center. Novel coronavirus infection control and guidance center in ultrasound department (First Edition).
[6] China-Japan Friendship Hospital Management Regulations on Medical Protective Products During the Epidemic of Novel Coronavirus-infected Pneumonia.
[7] National Health Commission. Guidelines for the Use of Common Medical Protective Products in the Prevention and Control of Novel Coronavirus-infected Pneumonia (Trial).(GWB YH [2020] No.75)
[8] World Health Organization. Summary of probable SARS cases with onset of illness from 1 November 2002 to 31 July 2003 (Based on data as of the 31 December 2003). Available from: https://www.who.int/csr/sars/country/table2004_04_21/en/
[9] de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 2016; 14:523-34.
[10] Pang X, Zhu Z, Xu F, Guo J, Gong X, Liu D, et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA 2003; 290:3215-21.
[11] Svoboda T, Henry B, Shulman L, Kennedy E, Rea E, Ng W, et al. Public health measures to control the spread of the severe acute respiratory syndrome during the outbreak in Toronto. N Engl J Med 2004; 350:2352-61.
[12] World Health Organization. Advice on the use of masks in the community, Advice on the use of masks in the community , during home care and in healthcare settings in the context of the novel coronavirus ( COVID - 19 ) outbreak. Available from: https://www.who.int/publications-detail/advice-on-the-use-of-masks-in-the-community-during-home-care-and-in-healthcare-settings-in-the-context-of-the-novel-coronavirus-(2019-ncov)-outbreak - 60k.
[13] Smith JD, MacDougall CC, Johnstone J, Copes RA, Schwartz B, Garber GE. Effectiveness of N95 respirators versus surgical masks in protecting health care workers from acute respiratory infection: a systematic review and meta-analysis. CMAJ 2016; 188:567-574.
[14] Loeb M, Dafoe N, Mahony J, John M, Sarabia A, Glavin V, et al. Surgical mask vs N95 respirator for preventing influenza among health care workers: a randomized trial. JAMA 2009; 302:1865-71.
[15] Loftus MJ, Guitart C, Tartari E, Stewardson AJ, Amer F, Bellissimo-Rodrigues F, et al. Hand hygiene in low- and middle-income countries. Int J Infect Dis 2019; 86:25-30.
[16] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497-506.
[17] Bai Y, Yao L, Wei T, Tian F, Jin DY, Chen L, et al. Presumed Asymptomatic Carrier Transmission of COVID-19. JAMA 2020:e202565.
[18] Nishiura H, Kobayashi T, Suzuki A, Jung SM, Hayashi K, Kinoshita R, et al. Estimation of the asymptomatic ratio of novel coronavirus infections (COVID-19). Int J Infect Dis 2020: S1201-9712(20) 30139-9. DOI: 10.1016/j.ijid.2020.03.020.
[19] Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020. Euro Surveill 2020; 25:2000180. DOI: 10.2807/1560-7917.ES.2020.25.10.2000180.
[20] World Health OrganizationM. Latest updates - Live press conference (Geneva).(accessed April 12, 2020). Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019.
Outlines

/